PANADOL

This brand name is authorized in Australia, Cyprus, Estonia, Finland, Hong Kong, Croatia, Ireland, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug PANADOL contains one active pharmaceutical ingredient (API):

1 Paracetamol
UNII 362O9ITL9D - ACETAMINOPHEN

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.

Read about Paracetamol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PANADOL BABY Oral suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PANADOL ORIGINAL Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02BE01 Paracetamol N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides
Discover more medicines within N02BE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 12210P
Country: EE Ravimiamet Identifier(s): 1009123, 1009145, 1076116, 1076127, 1076138, 1076149, 1076150, 1076161, 1076172, 1076183, 1076194, 1434787, 1434798, 1434800, 1434811, 1496033, 1496044, 1496055, 1496066, 1496077, 1496088, 1496099, 1496101, 1496112, 1496123, 1496134, 1496145, 1496156, 1496167, 1496178, 1531808, 1531819, 1531820, 1531842, 1531853
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 004524, 008259, 049134, 057965, 070745, 108221, 134353, 383992, 397302, 405069, 412630, 449174, 492793, 502182, 502735, 503831, 519580, 533406, 583638
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 149726, 149727, 18571, 325205, 46231
Country: HK Department of Health Drug Office Identifier(s): 02280, 27104, 27105, 31209, 40505, 49376, 49789, 51314, 51316, 51472, 52665, 52683, 52694, 52933, 53362, 53813, 59436
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1007942, 1007943, 1008529, 1008530, 1016505, 1056329, 1056330, 1056331, 1056332, 1061394, 1061395, 1063045, 1063046, 1063047, 1063048, 1063049, 1066418, 1066419, 1066420, 1070098, 1070099, 1070100, 1082881
Country: MT Medicines Authority Identifier(s): AA1177/00501, AA908/09101, MA1177/00503, MA1177/00504, MA460/00302, MA460/00303, PI274/01201A
Country: NL Z-Index G-Standaard, PRK Identifier(s): 18120, 19720, 48267, 56006, 81442
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10741, 11170, 11303, 12979, 12981, 13717, 14141, 14212, 15103, 15104, 21609, 21610, 236, 247, 8657
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100051046, 100051081, 100051098, 100110211, 100182854, 100282640, 100301431
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64145002, W64145003, W64145004, W64146001, W64146002, W64146003, W64146004, W64146005, W64146006, W64146007, W64146008, W64146009, W64146010, W64146011, W64146012, W64146013, W64146014, W64146015, W64146016, W64146017, W64146018
Country: SG Health Sciences Authority Identifier(s): 05919P, 05921P, 05922P, 07404P, 08739P, 10855P, 11734P, 11987P, 12406P, 13031P, 14699P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 9253191, 9253192, 9253193H, 9253194
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681291090035, 8681291090530, 8699522285945

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.